nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM3—epilepsy syndrome	0.23	0.371	CbGaD
Dicyclomine—CHRM1—epilepsy syndrome	0.214	0.346	CbGaD
Dicyclomine—CHRM2—epilepsy syndrome	0.175	0.283	CbGaD
Dicyclomine—CYP1A1—Propofol—epilepsy syndrome	0.0498	0.511	CbGbCtD
Dicyclomine—CYP1A1—Phenobarbital—epilepsy syndrome	0.0476	0.489	CbGbCtD
Dicyclomine—Pruritus—Felbamate—epilepsy syndrome	8.36e-05	0.000406	CcSEcCtD
Dicyclomine—Abdominal pain—Carbamazepine—epilepsy syndrome	8.36e-05	0.000406	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.36e-05	0.000406	CcSEcCtD
Dicyclomine—Ill-defined disorder—Pregabalin—epilepsy syndrome	8.35e-05	0.000406	CcSEcCtD
Dicyclomine—Rash—Levetiracetam—epilepsy syndrome	8.32e-05	0.000404	CcSEcCtD
Dicyclomine—Dermatitis—Levetiracetam—epilepsy syndrome	8.31e-05	0.000404	CcSEcCtD
Dicyclomine—Asthenia—Zonisamide—epilepsy syndrome	8.3e-05	0.000404	CcSEcCtD
Dicyclomine—Mental disorder—Gabapentin—epilepsy syndrome	8.3e-05	0.000403	CcSEcCtD
Dicyclomine—Dry mouth—Valproic Acid—epilepsy syndrome	8.28e-05	0.000403	CcSEcCtD
Dicyclomine—Agitation—Pregabalin—epilepsy syndrome	8.27e-05	0.000402	CcSEcCtD
Dicyclomine—Headache—Levetiracetam—epilepsy syndrome	8.26e-05	0.000402	CcSEcCtD
Dicyclomine—Erythema—Gabapentin—epilepsy syndrome	8.25e-05	0.000401	CcSEcCtD
Dicyclomine—Angioedema—Pregabalin—epilepsy syndrome	8.22e-05	0.000399	CcSEcCtD
Dicyclomine—Hypersensitivity—Clonazepam—epilepsy syndrome	8.22e-05	0.000399	CcSEcCtD
Dicyclomine—Dizziness—Vigabatrin—epilepsy syndrome	8.2e-05	0.000399	CcSEcCtD
Dicyclomine—Confusional state—Valproic Acid—epilepsy syndrome	8.19e-05	0.000398	CcSEcCtD
Dicyclomine—Pruritus—Zonisamide—epilepsy syndrome	8.19e-05	0.000398	CcSEcCtD
Dicyclomine—Hypersensitivity—Phenytoin—epilepsy syndrome	8.16e-05	0.000397	CcSEcCtD
Dicyclomine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	8.12e-05	0.000395	CcSEcCtD
Dicyclomine—Oedema—Valproic Acid—epilepsy syndrome	8.12e-05	0.000395	CcSEcCtD
Dicyclomine—Urticaria—Lamotrigine—epilepsy syndrome	8.12e-05	0.000395	CcSEcCtD
Dicyclomine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	8.12e-05	0.000395	CcSEcCtD
Dicyclomine—Malaise—Pregabalin—epilepsy syndrome	8.11e-05	0.000394	CcSEcCtD
Dicyclomine—Nausea—Propofol—epilepsy syndrome	8.11e-05	0.000394	CcSEcCtD
Dicyclomine—Tension—Gabapentin—epilepsy syndrome	8.09e-05	0.000393	CcSEcCtD
Dicyclomine—Vomiting—Fosphenytoin—epilepsy syndrome	8.09e-05	0.000393	CcSEcCtD
Dicyclomine—Abdominal pain—Lamotrigine—epilepsy syndrome	8.08e-05	0.000393	CcSEcCtD
Dicyclomine—Dizziness—Diazepam—epilepsy syndrome	8.08e-05	0.000393	CcSEcCtD
Dicyclomine—Syncope—Pregabalin—epilepsy syndrome	8.07e-05	0.000392	CcSEcCtD
Dicyclomine—Rash—Fosphenytoin—epilepsy syndrome	8.03e-05	0.00039	CcSEcCtD
Dicyclomine—Dermatitis—Fosphenytoin—epilepsy syndrome	8.02e-05	0.00039	CcSEcCtD
Dicyclomine—Nervousness—Gabapentin—epilepsy syndrome	8.01e-05	0.000389	CcSEcCtD
Dicyclomine—Asthenia—Clonazepam—epilepsy syndrome	8e-05	0.000389	CcSEcCtD
Dicyclomine—Headache—Fosphenytoin—epilepsy syndrome	7.97e-05	0.000388	CcSEcCtD
Dicyclomine—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.96e-05	0.000387	CcSEcCtD
Dicyclomine—Palpitations—Pregabalin—epilepsy syndrome	7.95e-05	0.000386	CcSEcCtD
Dicyclomine—Asthenia—Phenytoin—epilepsy syndrome	7.95e-05	0.000386	CcSEcCtD
Dicyclomine—Nausea—Midazolam—epilepsy syndrome	7.93e-05	0.000386	CcSEcCtD
Dicyclomine—Hypoaesthesia—Topiramate—epilepsy syndrome	7.93e-05	0.000386	CcSEcCtD
Dicyclomine—Hallucination—Topiramate—epilepsy syndrome	7.93e-05	0.000386	CcSEcCtD
Dicyclomine—Tachycardia—Valproic Acid—epilepsy syndrome	7.93e-05	0.000385	CcSEcCtD
Dicyclomine—Loss of consciousness—Pregabalin—epilepsy syndrome	7.91e-05	0.000384	CcSEcCtD
Dicyclomine—Asthenia—Oxcarbazepine—epilepsy syndrome	7.91e-05	0.000384	CcSEcCtD
Dicyclomine—Pruritus—Clonazepam—epilepsy syndrome	7.89e-05	0.000383	CcSEcCtD
Dicyclomine—Vomiting—Vigabatrin—epilepsy syndrome	7.89e-05	0.000383	CcSEcCtD
Dicyclomine—Pruritus—Phenytoin—epilepsy syndrome	7.84e-05	0.000381	CcSEcCtD
Dicyclomine—Nausea—Levetiracetam—epilepsy syndrome	7.83e-05	0.000381	CcSEcCtD
Dicyclomine—Rash—Vigabatrin—epilepsy syndrome	7.82e-05	0.00038	CcSEcCtD
Dicyclomine—Dizziness—Felbamate—epilepsy syndrome	7.82e-05	0.00038	CcSEcCtD
Dicyclomine—Dermatitis—Vigabatrin—epilepsy syndrome	7.82e-05	0.00038	CcSEcCtD
Dicyclomine—Pruritus—Oxcarbazepine—epilepsy syndrome	7.8e-05	0.000379	CcSEcCtD
Dicyclomine—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.79e-05	0.000379	CcSEcCtD
Dicyclomine—Vision blurred—Gabapentin—epilepsy syndrome	7.77e-05	0.000378	CcSEcCtD
Dicyclomine—Headache—Vigabatrin—epilepsy syndrome	7.77e-05	0.000378	CcSEcCtD
Dicyclomine—Hypertension—Pregabalin—epilepsy syndrome	7.77e-05	0.000377	CcSEcCtD
Dicyclomine—Vomiting—Diazepam—epilepsy syndrome	7.77e-05	0.000377	CcSEcCtD
Dicyclomine—Anorexia—Valproic Acid—epilepsy syndrome	7.74e-05	0.000376	CcSEcCtD
Dicyclomine—Rash—Diazepam—epilepsy syndrome	7.7e-05	0.000374	CcSEcCtD
Dicyclomine—Dermatitis—Diazepam—epilepsy syndrome	7.69e-05	0.000374	CcSEcCtD
Dicyclomine—Ill-defined disorder—Gabapentin—epilepsy syndrome	7.65e-05	0.000372	CcSEcCtD
Dicyclomine—Dizziness—Zonisamide—epilepsy syndrome	7.65e-05	0.000372	CcSEcCtD
Dicyclomine—Headache—Diazepam—epilepsy syndrome	7.65e-05	0.000372	CcSEcCtD
Dicyclomine—Asthenia—Carbamazepine—epilepsy syndrome	7.59e-05	0.000369	CcSEcCtD
Dicyclomine—Agitation—Gabapentin—epilepsy syndrome	7.58e-05	0.000368	CcSEcCtD
Dicyclomine—Discomfort—Pregabalin—epilepsy syndrome	7.57e-05	0.000368	CcSEcCtD
Dicyclomine—Nausea—Fosphenytoin—epilepsy syndrome	7.56e-05	0.000367	CcSEcCtD
Dicyclomine—Angioedema—Gabapentin—epilepsy syndrome	7.54e-05	0.000366	CcSEcCtD
Dicyclomine—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.53e-05	0.000366	CcSEcCtD
Dicyclomine—Vomiting—Felbamate—epilepsy syndrome	7.52e-05	0.000365	CcSEcCtD
Dicyclomine—Dry mouth—Pregabalin—epilepsy syndrome	7.49e-05	0.000364	CcSEcCtD
Dicyclomine—Pruritus—Carbamazepine—epilepsy syndrome	7.48e-05	0.000364	CcSEcCtD
Dicyclomine—Rash—Felbamate—epilepsy syndrome	7.45e-05	0.000362	CcSEcCtD
Dicyclomine—Eye disorder—Topiramate—epilepsy syndrome	7.45e-05	0.000362	CcSEcCtD
Dicyclomine—Dermatitis—Felbamate—epilepsy syndrome	7.45e-05	0.000362	CcSEcCtD
Dicyclomine—Malaise—Gabapentin—epilepsy syndrome	7.44e-05	0.000362	CcSEcCtD
Dicyclomine—Headache—Felbamate—epilepsy syndrome	7.41e-05	0.00036	CcSEcCtD
Dicyclomine—Confusional state—Pregabalin—epilepsy syndrome	7.4e-05	0.00036	CcSEcCtD
Dicyclomine—Cardiac disorder—Topiramate—epilepsy syndrome	7.4e-05	0.00036	CcSEcCtD
Dicyclomine—Syncope—Gabapentin—epilepsy syndrome	7.4e-05	0.00036	CcSEcCtD
Dicyclomine—Dizziness—Clonazepam—epilepsy syndrome	7.37e-05	0.000358	CcSEcCtD
Dicyclomine—Nausea—Vigabatrin—epilepsy syndrome	7.37e-05	0.000358	CcSEcCtD
Dicyclomine—Vomiting—Zonisamide—epilepsy syndrome	7.36e-05	0.000358	CcSEcCtD
Dicyclomine—Insomnia—Valproic Acid—epilepsy syndrome	7.34e-05	0.000357	CcSEcCtD
Dicyclomine—Oedema—Pregabalin—epilepsy syndrome	7.34e-05	0.000357	CcSEcCtD
Dicyclomine—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.34e-05	0.000357	CcSEcCtD
Dicyclomine—Asthenia—Lamotrigine—epilepsy syndrome	7.33e-05	0.000356	CcSEcCtD
Dicyclomine—Dizziness—Phenytoin—epilepsy syndrome	7.33e-05	0.000356	CcSEcCtD
Dicyclomine—Rash—Zonisamide—epilepsy syndrome	7.3e-05	0.000355	CcSEcCtD
Dicyclomine—Paraesthesia—Valproic Acid—epilepsy syndrome	7.29e-05	0.000354	CcSEcCtD
Dicyclomine—Palpitations—Gabapentin—epilepsy syndrome	7.29e-05	0.000354	CcSEcCtD
Dicyclomine—Dermatitis—Zonisamide—epilepsy syndrome	7.29e-05	0.000354	CcSEcCtD
Dicyclomine—Dizziness—Oxcarbazepine—epilepsy syndrome	7.29e-05	0.000354	CcSEcCtD
Dicyclomine—Nausea—Diazepam—epilepsy syndrome	7.25e-05	0.000353	CcSEcCtD
Dicyclomine—Loss of consciousness—Gabapentin—epilepsy syndrome	7.25e-05	0.000352	CcSEcCtD
Dicyclomine—Headache—Zonisamide—epilepsy syndrome	7.25e-05	0.000352	CcSEcCtD
Dicyclomine—Dyspnoea—Valproic Acid—epilepsy syndrome	7.24e-05	0.000352	CcSEcCtD
Dicyclomine—Pruritus—Lamotrigine—epilepsy syndrome	7.23e-05	0.000351	CcSEcCtD
Dicyclomine—Shock—Pregabalin—epilepsy syndrome	7.22e-05	0.000351	CcSEcCtD
Dicyclomine—Somnolence—Valproic Acid—epilepsy syndrome	7.22e-05	0.000351	CcSEcCtD
Dicyclomine—Immune system disorder—Topiramate—epilepsy syndrome	7.2e-05	0.00035	CcSEcCtD
Dicyclomine—Nervous system disorder—Pregabalin—epilepsy syndrome	7.2e-05	0.00035	CcSEcCtD
Dicyclomine—Mediastinal disorder—Topiramate—epilepsy syndrome	7.18e-05	0.000349	CcSEcCtD
Dicyclomine—Tachycardia—Pregabalin—epilepsy syndrome	7.17e-05	0.000348	CcSEcCtD
Dicyclomine—Dyspepsia—Valproic Acid—epilepsy syndrome	7.15e-05	0.000347	CcSEcCtD
Dicyclomine—Hypertension—Gabapentin—epilepsy syndrome	7.12e-05	0.000346	CcSEcCtD
Dicyclomine—Vomiting—Clonazepam—epilepsy syndrome	7.09e-05	0.000345	CcSEcCtD
Dicyclomine—Decreased appetite—Valproic Acid—epilepsy syndrome	7.06e-05	0.000343	CcSEcCtD
Dicyclomine—Vomiting—Phenytoin—epilepsy syndrome	7.04e-05	0.000342	CcSEcCtD
Dicyclomine—Rash—Clonazepam—epilepsy syndrome	7.03e-05	0.000342	CcSEcCtD
Dicyclomine—Dermatitis—Clonazepam—epilepsy syndrome	7.03e-05	0.000341	CcSEcCtD
Dicyclomine—Nausea—Felbamate—epilepsy syndrome	7.02e-05	0.000341	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.01e-05	0.000341	CcSEcCtD
Dicyclomine—Vomiting—Oxcarbazepine—epilepsy syndrome	7.01e-05	0.000341	CcSEcCtD
Dicyclomine—Fatigue—Valproic Acid—epilepsy syndrome	7e-05	0.00034	CcSEcCtD
Dicyclomine—Anorexia—Pregabalin—epilepsy syndrome	7e-05	0.00034	CcSEcCtD
Dicyclomine—Dizziness—Carbamazepine—epilepsy syndrome	6.99e-05	0.00034	CcSEcCtD
Dicyclomine—Headache—Clonazepam—epilepsy syndrome	6.99e-05	0.00034	CcSEcCtD
Dicyclomine—Rash—Phenytoin—epilepsy syndrome	6.98e-05	0.000339	CcSEcCtD
Dicyclomine—Mental disorder—Topiramate—epilepsy syndrome	6.98e-05	0.000339	CcSEcCtD
Dicyclomine—Dermatitis—Phenytoin—epilepsy syndrome	6.98e-05	0.000339	CcSEcCtD
Dicyclomine—Rash—Oxcarbazepine—epilepsy syndrome	6.95e-05	0.000338	CcSEcCtD
Dicyclomine—Pain—Valproic Acid—epilepsy syndrome	6.94e-05	0.000338	CcSEcCtD
Dicyclomine—Constipation—Valproic Acid—epilepsy syndrome	6.94e-05	0.000338	CcSEcCtD
Dicyclomine—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.94e-05	0.000337	CcSEcCtD
Dicyclomine—Headache—Phenytoin—epilepsy syndrome	6.94e-05	0.000337	CcSEcCtD
Dicyclomine—Erythema—Topiramate—epilepsy syndrome	6.94e-05	0.000337	CcSEcCtD
Dicyclomine—Discomfort—Gabapentin—epilepsy syndrome	6.94e-05	0.000337	CcSEcCtD
Dicyclomine—Headache—Oxcarbazepine—epilepsy syndrome	6.9e-05	0.000336	CcSEcCtD
Dicyclomine—Nausea—Zonisamide—epilepsy syndrome	6.87e-05	0.000334	CcSEcCtD
Dicyclomine—Dry mouth—Gabapentin—epilepsy syndrome	6.87e-05	0.000334	CcSEcCtD
Dicyclomine—Tension—Topiramate—epilepsy syndrome	6.81e-05	0.000331	CcSEcCtD
Dicyclomine—Confusional state—Gabapentin—epilepsy syndrome	6.79e-05	0.00033	CcSEcCtD
Dicyclomine—Dizziness—Lamotrigine—epilepsy syndrome	6.76e-05	0.000328	CcSEcCtD
Dicyclomine—Nervousness—Topiramate—epilepsy syndrome	6.74e-05	0.000328	CcSEcCtD
Dicyclomine—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.73e-05	0.000327	CcSEcCtD
Dicyclomine—Oedema—Gabapentin—epilepsy syndrome	6.73e-05	0.000327	CcSEcCtD
Dicyclomine—Vomiting—Carbamazepine—epilepsy syndrome	6.72e-05	0.000327	CcSEcCtD
Dicyclomine—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.69e-05	0.000325	CcSEcCtD
Dicyclomine—Rash—Carbamazepine—epilepsy syndrome	6.67e-05	0.000324	CcSEcCtD
Dicyclomine—Dermatitis—Carbamazepine—epilepsy syndrome	6.66e-05	0.000324	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.64e-05	0.000323	CcSEcCtD
Dicyclomine—Insomnia—Pregabalin—epilepsy syndrome	6.64e-05	0.000323	CcSEcCtD
Dicyclomine—Nausea—Clonazepam—epilepsy syndrome	6.62e-05	0.000322	CcSEcCtD
Dicyclomine—Headache—Carbamazepine—epilepsy syndrome	6.62e-05	0.000322	CcSEcCtD
Dicyclomine—Shock—Gabapentin—epilepsy syndrome	6.62e-05	0.000322	CcSEcCtD
Dicyclomine—Nervous system disorder—Gabapentin—epilepsy syndrome	6.6e-05	0.000321	CcSEcCtD
Dicyclomine—Paraesthesia—Pregabalin—epilepsy syndrome	6.59e-05	0.00032	CcSEcCtD
Dicyclomine—Nausea—Phenytoin—epilepsy syndrome	6.58e-05	0.00032	CcSEcCtD
Dicyclomine—Tachycardia—Gabapentin—epilepsy syndrome	6.57e-05	0.000319	CcSEcCtD
Dicyclomine—Dyspnoea—Pregabalin—epilepsy syndrome	6.55e-05	0.000318	CcSEcCtD
Dicyclomine—Nausea—Oxcarbazepine—epilepsy syndrome	6.55e-05	0.000318	CcSEcCtD
Dicyclomine—Vision blurred—Topiramate—epilepsy syndrome	6.54e-05	0.000318	CcSEcCtD
Dicyclomine—Somnolence—Pregabalin—epilepsy syndrome	6.53e-05	0.000317	CcSEcCtD
Dicyclomine—Vomiting—Lamotrigine—epilepsy syndrome	6.5e-05	0.000316	CcSEcCtD
Dicyclomine—Urticaria—Valproic Acid—epilepsy syndrome	6.45e-05	0.000314	CcSEcCtD
Dicyclomine—Rash—Lamotrigine—epilepsy syndrome	6.44e-05	0.000313	CcSEcCtD
Dicyclomine—Ill-defined disorder—Topiramate—epilepsy syndrome	6.44e-05	0.000313	CcSEcCtD
Dicyclomine—Dermatitis—Lamotrigine—epilepsy syndrome	6.44e-05	0.000313	CcSEcCtD
Dicyclomine—Abdominal pain—Valproic Acid—epilepsy syndrome	6.42e-05	0.000312	CcSEcCtD
Dicyclomine—Anorexia—Gabapentin—epilepsy syndrome	6.42e-05	0.000312	CcSEcCtD
Dicyclomine—Headache—Lamotrigine—epilepsy syndrome	6.4e-05	0.000311	CcSEcCtD
Dicyclomine—Decreased appetite—Pregabalin—epilepsy syndrome	6.38e-05	0.00031	CcSEcCtD
Dicyclomine—Agitation—Topiramate—epilepsy syndrome	6.38e-05	0.00031	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.34e-05	0.000308	CcSEcCtD
Dicyclomine—Fatigue—Pregabalin—epilepsy syndrome	6.33e-05	0.000308	CcSEcCtD
Dicyclomine—Nausea—Carbamazepine—epilepsy syndrome	6.28e-05	0.000305	CcSEcCtD
Dicyclomine—Pain—Pregabalin—epilepsy syndrome	6.28e-05	0.000305	CcSEcCtD
Dicyclomine—Constipation—Pregabalin—epilepsy syndrome	6.28e-05	0.000305	CcSEcCtD
Dicyclomine—Malaise—Topiramate—epilepsy syndrome	6.26e-05	0.000304	CcSEcCtD
Dicyclomine—Syncope—Topiramate—epilepsy syndrome	6.22e-05	0.000302	CcSEcCtD
Dicyclomine—Palpitations—Topiramate—epilepsy syndrome	6.13e-05	0.000298	CcSEcCtD
Dicyclomine—Loss of consciousness—Topiramate—epilepsy syndrome	6.1e-05	0.000296	CcSEcCtD
Dicyclomine—Insomnia—Gabapentin—epilepsy syndrome	6.09e-05	0.000296	CcSEcCtD
Dicyclomine—Nausea—Lamotrigine—epilepsy syndrome	6.07e-05	0.000295	CcSEcCtD
Dicyclomine—Feeling abnormal—Pregabalin—epilepsy syndrome	6.05e-05	0.000294	CcSEcCtD
Dicyclomine—Paraesthesia—Gabapentin—epilepsy syndrome	6.04e-05	0.000294	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6e-05	0.000292	CcSEcCtD
Dicyclomine—Dyspnoea—Gabapentin—epilepsy syndrome	6e-05	0.000292	CcSEcCtD
Dicyclomine—Hypertension—Topiramate—epilepsy syndrome	5.99e-05	0.000291	CcSEcCtD
Dicyclomine—Somnolence—Gabapentin—epilepsy syndrome	5.98e-05	0.000291	CcSEcCtD
Dicyclomine—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.98e-05	0.000291	CcSEcCtD
Dicyclomine—Dyspepsia—Gabapentin—epilepsy syndrome	5.93e-05	0.000288	CcSEcCtD
Dicyclomine—Decreased appetite—Gabapentin—epilepsy syndrome	5.85e-05	0.000284	CcSEcCtD
Dicyclomine—Discomfort—Topiramate—epilepsy syndrome	5.84e-05	0.000284	CcSEcCtD
Dicyclomine—Urticaria—Pregabalin—epilepsy syndrome	5.83e-05	0.000283	CcSEcCtD
Dicyclomine—Asthenia—Valproic Acid—epilepsy syndrome	5.83e-05	0.000283	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.81e-05	0.000282	CcSEcCtD
Dicyclomine—Fatigue—Gabapentin—epilepsy syndrome	5.8e-05	0.000282	CcSEcCtD
Dicyclomine—Abdominal pain—Pregabalin—epilepsy syndrome	5.8e-05	0.000282	CcSEcCtD
Dicyclomine—Dry mouth—Topiramate—epilepsy syndrome	5.78e-05	0.000281	CcSEcCtD
Dicyclomine—Pain—Gabapentin—epilepsy syndrome	5.76e-05	0.00028	CcSEcCtD
Dicyclomine—Constipation—Gabapentin—epilepsy syndrome	5.76e-05	0.00028	CcSEcCtD
Dicyclomine—Pruritus—Valproic Acid—epilepsy syndrome	5.75e-05	0.000279	CcSEcCtD
Dicyclomine—Confusional state—Topiramate—epilepsy syndrome	5.71e-05	0.000278	CcSEcCtD
Dicyclomine—Oedema—Topiramate—epilepsy syndrome	5.66e-05	0.000275	CcSEcCtD
Dicyclomine—Shock—Topiramate—epilepsy syndrome	5.57e-05	0.000271	CcSEcCtD
Dicyclomine—Nervous system disorder—Topiramate—epilepsy syndrome	5.55e-05	0.00027	CcSEcCtD
Dicyclomine—Feeling abnormal—Gabapentin—epilepsy syndrome	5.55e-05	0.00027	CcSEcCtD
Dicyclomine—Tachycardia—Topiramate—epilepsy syndrome	5.53e-05	0.000269	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.5e-05	0.000268	CcSEcCtD
Dicyclomine—Hypersensitivity—Pregabalin—epilepsy syndrome	5.41e-05	0.000263	CcSEcCtD
Dicyclomine—Anorexia—Topiramate—epilepsy syndrome	5.4e-05	0.000262	CcSEcCtD
Dicyclomine—Dizziness—Valproic Acid—epilepsy syndrome	5.37e-05	0.000261	CcSEcCtD
Dicyclomine—Urticaria—Gabapentin—epilepsy syndrome	5.35e-05	0.00026	CcSEcCtD
Dicyclomine—Abdominal pain—Gabapentin—epilepsy syndrome	5.32e-05	0.000259	CcSEcCtD
Dicyclomine—Asthenia—Pregabalin—epilepsy syndrome	5.27e-05	0.000256	CcSEcCtD
Dicyclomine—Pruritus—Pregabalin—epilepsy syndrome	5.19e-05	0.000252	CcSEcCtD
Dicyclomine—Vomiting—Valproic Acid—epilepsy syndrome	5.16e-05	0.000251	CcSEcCtD
Dicyclomine—Insomnia—Topiramate—epilepsy syndrome	5.12e-05	0.000249	CcSEcCtD
Dicyclomine—Rash—Valproic Acid—epilepsy syndrome	5.12e-05	0.000249	CcSEcCtD
Dicyclomine—Dermatitis—Valproic Acid—epilepsy syndrome	5.12e-05	0.000249	CcSEcCtD
Dicyclomine—Headache—Valproic Acid—epilepsy syndrome	5.09e-05	0.000247	CcSEcCtD
Dicyclomine—Paraesthesia—Topiramate—epilepsy syndrome	5.09e-05	0.000247	CcSEcCtD
Dicyclomine—Dyspnoea—Topiramate—epilepsy syndrome	5.05e-05	0.000245	CcSEcCtD
Dicyclomine—Somnolence—Topiramate—epilepsy syndrome	5.04e-05	0.000245	CcSEcCtD
Dicyclomine—Dyspepsia—Topiramate—epilepsy syndrome	4.99e-05	0.000242	CcSEcCtD
Dicyclomine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.96e-05	0.000241	CcSEcCtD
Dicyclomine—Decreased appetite—Topiramate—epilepsy syndrome	4.92e-05	0.000239	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.89e-05	0.000238	CcSEcCtD
Dicyclomine—Fatigue—Topiramate—epilepsy syndrome	4.88e-05	0.000237	CcSEcCtD
Dicyclomine—Dizziness—Pregabalin—epilepsy syndrome	4.85e-05	0.000236	CcSEcCtD
Dicyclomine—Pain—Topiramate—epilepsy syndrome	4.84e-05	0.000235	CcSEcCtD
Dicyclomine—Constipation—Topiramate—epilepsy syndrome	4.84e-05	0.000235	CcSEcCtD
Dicyclomine—Asthenia—Gabapentin—epilepsy syndrome	4.83e-05	0.000235	CcSEcCtD
Dicyclomine—Nausea—Valproic Acid—epilepsy syndrome	4.82e-05	0.000234	CcSEcCtD
Dicyclomine—Pruritus—Gabapentin—epilepsy syndrome	4.76e-05	0.000231	CcSEcCtD
Dicyclomine—Vomiting—Pregabalin—epilepsy syndrome	4.67e-05	0.000227	CcSEcCtD
Dicyclomine—Feeling abnormal—Topiramate—epilepsy syndrome	4.67e-05	0.000227	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.63e-05	0.000225	CcSEcCtD
Dicyclomine—Rash—Pregabalin—epilepsy syndrome	4.63e-05	0.000225	CcSEcCtD
Dicyclomine—Dermatitis—Pregabalin—epilepsy syndrome	4.62e-05	0.000225	CcSEcCtD
Dicyclomine—Headache—Pregabalin—epilepsy syndrome	4.6e-05	0.000224	CcSEcCtD
Dicyclomine—Urticaria—Topiramate—epilepsy syndrome	4.5e-05	0.000219	CcSEcCtD
Dicyclomine—Abdominal pain—Topiramate—epilepsy syndrome	4.48e-05	0.000218	CcSEcCtD
Dicyclomine—Dizziness—Gabapentin—epilepsy syndrome	4.45e-05	0.000216	CcSEcCtD
Dicyclomine—Nausea—Pregabalin—epilepsy syndrome	4.36e-05	0.000212	CcSEcCtD
Dicyclomine—Vomiting—Gabapentin—epilepsy syndrome	4.28e-05	0.000208	CcSEcCtD
Dicyclomine—Rash—Gabapentin—epilepsy syndrome	4.24e-05	0.000206	CcSEcCtD
Dicyclomine—Dermatitis—Gabapentin—epilepsy syndrome	4.24e-05	0.000206	CcSEcCtD
Dicyclomine—Headache—Gabapentin—epilepsy syndrome	4.22e-05	0.000205	CcSEcCtD
Dicyclomine—Hypersensitivity—Topiramate—epilepsy syndrome	4.17e-05	0.000203	CcSEcCtD
Dicyclomine—Asthenia—Topiramate—epilepsy syndrome	4.06e-05	0.000198	CcSEcCtD
Dicyclomine—Pruritus—Topiramate—epilepsy syndrome	4.01e-05	0.000195	CcSEcCtD
Dicyclomine—Nausea—Gabapentin—epilepsy syndrome	4e-05	0.000194	CcSEcCtD
Dicyclomine—Dizziness—Topiramate—epilepsy syndrome	3.75e-05	0.000182	CcSEcCtD
Dicyclomine—Vomiting—Topiramate—epilepsy syndrome	3.6e-05	0.000175	CcSEcCtD
Dicyclomine—Rash—Topiramate—epilepsy syndrome	3.57e-05	0.000174	CcSEcCtD
Dicyclomine—Dermatitis—Topiramate—epilepsy syndrome	3.57e-05	0.000173	CcSEcCtD
Dicyclomine—Headache—Topiramate—epilepsy syndrome	3.55e-05	0.000172	CcSEcCtD
Dicyclomine—Nausea—Topiramate—epilepsy syndrome	3.36e-05	0.000164	CcSEcCtD
Dicyclomine—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.17e-05	0.000149	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.16e-05	0.000149	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	1.16e-05	0.000148	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.15e-05	0.000147	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.15e-05	0.000147	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.15e-05	0.000146	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	1.14e-05	0.000146	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.13e-05	0.000145	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	1.13e-05	0.000144	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.11e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	1.1e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.09e-05	0.000139	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.08e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.08e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.08e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.08e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.07e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.07e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.07e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.07e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.06e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.06e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.05e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.05e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.04e-05	0.000133	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.04e-05	0.000133	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.03e-05	0.000131	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	1.03e-05	0.000131	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	1.02e-05	0.000131	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.02e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	1.01e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.01e-05	0.000129	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PLCB1—epilepsy syndrome	1.01e-05	0.000129	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—TH—epilepsy syndrome	1.01e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	1e-05	0.000128	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	9.99e-06	0.000128	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	9.93e-06	0.000127	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	9.91e-06	0.000127	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.86e-06	0.000126	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	9.83e-06	0.000125	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	9.8e-06	0.000125	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	9.7e-06	0.000124	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.49e-06	0.000121	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	9.46e-06	0.000121	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	9.46e-06	0.000121	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.46e-06	0.000121	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	9.43e-06	0.00012	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	9.43e-06	0.00012	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.37e-06	0.00012	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	9.34e-06	0.000119	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	9.34e-06	0.000119	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	9.32e-06	0.000119	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	9.3e-06	0.000119	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	9.21e-06	0.000118	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	9.21e-06	0.000118	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	9.21e-06	0.000118	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	9.2e-06	0.000118	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	9.18e-06	0.000117	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	9.18e-06	0.000117	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SST—epilepsy syndrome	9.18e-06	0.000117	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	9.13e-06	0.000117	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	9.1e-06	0.000116	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	9.09e-06	0.000116	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	9.09e-06	0.000116	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	9.09e-06	0.000116	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	9.01e-06	0.000115	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	9.01e-06	0.000115	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.99e-06	0.000115	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	8.98e-06	0.000115	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	8.97e-06	0.000115	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	8.96e-06	0.000114	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	8.94e-06	0.000114	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	8.89e-06	0.000114	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	8.86e-06	0.000113	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	8.66e-06	0.000111	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	8.66e-06	0.000111	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	8.64e-06	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	8.63e-06	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	8.63e-06	0.00011	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	8.62e-06	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	8.62e-06	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	8.59e-06	0.00011	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	8.58e-06	0.00011	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	8.55e-06	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	8.54e-06	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	8.54e-06	0.000109	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	8.53e-06	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	8.53e-06	0.000109	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	8.51e-06	0.000109	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—BCHE—epilepsy syndrome	8.5e-06	0.000109	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	8.5e-06	0.000108	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	8.5e-06	0.000108	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	8.47e-06	0.000108	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	8.47e-06	0.000108	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	8.47e-06	0.000108	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	8.47e-06	0.000108	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	8.44e-06	0.000108	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMOX1—epilepsy syndrome	8.39e-06	0.000107	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	8.39e-06	0.000107	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	8.39e-06	0.000107	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	8.36e-06	0.000107	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	8.29e-06	0.000106	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAT—epilepsy syndrome	8.28e-06	0.000106	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	8.26e-06	0.000106	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	8.18e-06	0.000104	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	8.11e-06	0.000104	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	8.06e-06	0.000103	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	8.05e-06	0.000103	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	8.02e-06	0.000102	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	8.02e-06	0.000102	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—TH—epilepsy syndrome	7.99e-06	0.000102	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	7.94e-06	0.000101	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	7.9e-06	0.000101	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	7.87e-06	0.000101	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.86e-06	0.0001	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	7.85e-06	0.0001	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	7.82e-06	9.99e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	7.8e-06	9.96e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	7.75e-06	9.89e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	7.71e-06	9.85e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	7.69e-06	9.82e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	7.68e-06	9.81e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	7.66e-06	9.78e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	7.62e-06	9.73e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	7.58e-06	9.68e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPX1—epilepsy syndrome	7.49e-06	9.56e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	7.3e-06	9.32e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	7.27e-06	9.29e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	7.22e-06	9.23e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	7.21e-06	9.2e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	7.2e-06	9.2e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	7.2e-06	9.2e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	7.18e-06	9.17e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	7.13e-06	9.11e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	7.11e-06	9.08e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	6.98e-06	8.91e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	6.95e-06	8.88e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	6.89e-06	8.8e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	6.67e-06	8.51e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	6.6e-06	8.43e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAT—epilepsy syndrome	6.58e-06	8.4e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	6.58e-06	8.4e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AGT—epilepsy syndrome	6.57e-06	8.39e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	6.51e-06	8.32e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—epilepsy syndrome	6.43e-06	8.22e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	6.42e-06	8.19e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	6.4e-06	8.17e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	6.4e-06	8.17e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	6.39e-06	8.16e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	6.38e-06	8.15e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	6.37e-06	8.14e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	6.36e-06	8.12e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	6.33e-06	8.09e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	6.31e-06	8.06e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	6.3e-06	8.04e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.17e-06	7.88e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	6.15e-06	7.85e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	6.1e-06	7.79e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.09e-06	7.77e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	6.08e-06	7.76e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	6.02e-06	7.69e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—epilepsy syndrome	5.95e-06	7.6e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	5.93e-06	7.58e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	5.91e-06	7.55e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	5.86e-06	7.48e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	5.81e-06	7.41e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	5.79e-06	7.39e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	5.73e-06	7.32e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—POMC—epilepsy syndrome	5.53e-06	7.06e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	5.52e-06	7.04e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	5.51e-06	7.03e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	5.5e-06	7.02e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	5.49e-06	7.01e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	5.44e-06	6.95e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	5.44e-06	6.94e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	5.4e-06	6.89e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	5.38e-06	6.87e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	5.33e-06	6.8e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	5.29e-06	6.75e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	5.27e-06	6.73e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	5.22e-06	6.67e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AGT—epilepsy syndrome	5.22e-06	6.66e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—epilepsy syndrome	5.11e-06	6.53e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.09e-06	6.5e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	5.07e-06	6.48e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.07e-06	6.47e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	5.05e-06	6.45e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—epilepsy syndrome	5.04e-06	6.44e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	5.02e-06	6.42e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	5e-06	6.39e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.64e-06	5.92e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	4.62e-06	5.9e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	4.58e-06	5.84e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	4.54e-06	5.79e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	4.52e-06	5.77e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	4.48e-06	5.72e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	4.41e-06	5.63e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—POMC—epilepsy syndrome	4.39e-06	5.61e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.1e-06	5.24e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	4.09e-06	5.22e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	4.05e-06	5.17e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—epilepsy syndrome	4e-06	5.11e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.81e-06	4.86e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.79e-06	4.84e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.76e-06	4.8e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.73e-06	4.77e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.72e-06	4.75e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.68e-06	4.7e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	3.5e-06	4.47e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.46e-06	4.42e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	3.45e-06	4.41e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.43e-06	4.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	3.42e-06	4.37e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.42e-06	4.37e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	3.39e-06	4.33e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	3.33e-06	4.26e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	3.32e-06	4.24e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	3.29e-06	4.2e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.24e-06	4.14e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	3.23e-06	4.13e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	3.2e-06	4.09e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.15e-06	4.02e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	3.14e-06	4.01e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.11e-06	3.97e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.99e-06	3.82e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.98e-06	3.81e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.95e-06	3.77e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.91e-06	3.72e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.9e-06	3.71e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.88e-06	3.67e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—epilepsy syndrome	2.22e-06	2.83e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.86e-06	2.37e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.85e-06	2.37e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.83e-06	2.34e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.76e-06	2.25e-05	CbGpPWpGaD
